CRINETICS PHARMACEUTICALS IN COM

CRINETICS PHARMACEUTICALS IN COM is a security (CUSIP 22663K107) tracked across SEC portfolio filings. 268 institutional managers reported $4.1B on Form 13F as of 2026-06-30; 40 registered fund positions totaling $516.6M via N-PORT as of 2026-05-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 268 managers by value.

ManagerLocationValueShares
FMR LLCBOSTON, MA$572.4M15,759,799
VANGUARD GROUP INCValley Forge, PA$425.3M9,135,504
BlackRock, Inc.New York, NY$308.0M8,478,815
FARALLON CAPITAL MANAGEMENT LLCSAN FRANCISCO, CA$302.8M8,338,098
WELLINGTON MANAGEMENT GROUP LLPBOSTON, MA$296.3M8,157,204
Driehaus Capital Management LLCChicago, IL$232.3M6,395,922
JANUS HENDERSON GROUP PLCLONDON, X0$164.2M4,520,251
EcoR1 Capital, LLCSan Francisco, CA$155.7M4,288,120
Bellevue Group AGKuesnacht, V8$119.1M3,280,000
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$90.1M2,480,763
STATE STREET CORPBOSTON, MA$87.3M2,403,046
BAKER BROS. ADVISORS LPNEW YORK, NY$85.4M2,351,465
Pictet Asset Management Holding SACAROUGE, V8$77.6M2,075,375
Siren, L.L.C.New York, NY$69.1M1,903,636
BNP PARIBAS ASSET MANAGEMENT Holding S.A.Paris, I0$62.3M1,716,445

Top fund holders (N-PORT)

Showing 15 of 40 fund positions by value.

FundRegistrantValue% of fund
VANGUARD HEALTH CARE FUNDVANGUARD SPECIALIZED FUNDS$135.5M36.76%
T. Rowe Price New Horizons Fund, Inc.T. ROWE PRICE NEW HORIZONS FUND, INC.$57.5M44.99%
VANGUARD EXPLORER FUNDVANGUARD EXPLORER FUND$43.4M19.94%
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$41.5M5.09%
T. Rowe Price Health Sciences Fund, Inc.T. ROWE PRICE HEALTH SCIENCES FUND, INC.$39.8M36.49%
T. Rowe Price Small-Cap Stock Fund, Inc.T. ROWE PRICE SMALL-CAP STOCK FUND, INC.$28.2M34.88%
Fidelity Advisor Health Care FundFidelity Advisor Series VII$26.0M90.00%
Fidelity Growth Company FundFidelity Mt. Vernon Street Trust$19.9M2.01%
abrdn Healthcare Investorsabrdn Healthcare Investors$18.5M162.35%
VANGUARD RUSSELL 2000 INDEX FUNDVANGUARD SCOTTSDALE FUNDS$17.9M10.19%
T. Rowe Price Institutional Small-Cap Stock FundT. Rowe Price Equity Funds, Inc.$15.2M35.14%
abrdn Life Sciences Investorsabrdn Life Sciences Investors$11.3M202.15%
Janus Henderson Venture FundJANUS INVESTMENT FUND$11.0M36.02%
PGIM Jennison Health Sciences FundPrudential Sector Funds, Inc.$9.9M71.03%
Columbia Acorn FundCOLUMBIA ACORN TRUST$9.2M40.83%

More